Site ES34004

Madrid 28222

1 studies enrolling now · 6 studies all time

What they study most

Advanced Hepatocellular Carcinoma, Clostridium Difficile-associated Diarrhea (CDAD), Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma, Metastatic Hormone Sensitive Prostate Cancer, Overactive Bladder, Solid Tumor, Urgency Incontinence, Urinary Bladder Diseases\Urologic Diseases, Urinary Bladder Overactive

Studies at this site

• A Study of ASP3082 in Adults With Advanced Solid Tumors — Recruiting now
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
• A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) — Completed
• A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma — Completed
• A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) — Completed
• A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder — Completed